Nio stock tumbles on fourth-quarter miss, disappointing outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- S&P 500, Dow set to open lower as Gulf tensions send oil to over six-week high
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- Citi initiates UiPath coverage with Buy rating and $23 target
- Trump says Canada's Bombardier must build jets in US or lose market access
- European shares subdued as surging crude sharpens focus on ECB rate path
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- Alibaba (BABA) PT Lowered to $165 at Bernstein SocGen Group
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Citi Reiterates Buy Rating on NIO (NIO)
March 25, 2025 10:27 AM EDTCiti analyst Jeff Chung reiterated a Buy rating and $8.10 price target on NIO (NYSE: NIO).
The analyst comments "Cassava Sciences, Inc. (SAVA; Sell) announced topline results from the Phase 3 REFOCUS-ALZ study of simufilam in mild-to-moderate AD. Simufilam is a proprietary, investigational oral... More
NIO (NIO) PT Lowered to $4.90 at BofA Securities
March 21, 2025 2:40 PM EDTBofA Securities analyst Ming Hsun Lee lowered the price target on NIO (NYSE: NIO) to $4.90 (from $5.00) while maintaining a Neutral rating.
The analyst comments "Management guided 41-43k units of vehicle delivery (+36% to +43% YoY) and RMB12.4- 12.9bn (+25% to +30% YoY). Accordingly, we raise our... More
Morgan Stanley Reiterates Overweight Rating on NIO (NIO)
March 21, 2025 6:39 AM EDTMorgan Stanley analyst Tim Hsiao reiterated an Overweight rating and $5.90 price target on NIO (NYSE: NIO)
The analyst comments "NIO reported a net loss of Rmb7.1bn in 4Q24 (vs. Rmb5.1bn loss in 3Q24), higher than our expectation of a Rmb5.8bn loss. Full-year losses arrived at Rmb22.4bn vs. 20.7bn in... More
